Related Experiment Video
Updated: Nov 19, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients
Melanie Dubois1,2, Avika Dixit1,2, Gabriella Lamb1,2
1Boston Children's Hospital, Boston, MA, USA.
Pediatric solid organ and stem cell transplant recipients face high risks from tuberculosis (TB). Managing TB in these children is complex due to immunosuppression and drug interactions, requiring further research for better outcomes.
Area of Science:
- Pediatric medicine
- Infectious diseases
- Transplantation immunology
Background:
- Children undergoing transplantation are highly susceptible to tuberculosis (TB).
- Post-transplant TB presents significant morbidity and mortality risks.
- Management is complicated by immunosuppression and potential drug interactions.
Purpose of the Study:
- To review the current understanding of TB in pediatric transplant recipients.
- To address the unique challenges in managing TB in this population.
- To consolidate information on epidemiology, diagnosis, treatment, and prevention.
Main Methods:
- Literature review of existing studies and clinical data.
- Synthesis of current knowledge on TB in pediatric transplant patients.
- Analysis of challenges specific to immunosuppressed pediatric populations.
Main Results:
- TB poses a substantial threat to pediatric transplant recipients.
- Limited data exist on the specific management of TB in this group.
- Key challenges include diagnosis, treatment efficacy, and drug interactions.
Conclusions:
- Pediatric transplant recipients with TB require specialized care.
- Further research is essential to enhance diagnostic accuracy.
- Optimizing treatment strategies is crucial for improving patient outcomes.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

